Skip to main content
Log in

Quality of Life in Patients With Colorectal Metastasis and Intrahepatic Chemotherapy

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background:Liver metastasis from colorectal cancer remains an oncological challenge. Hepatic chemotherapy has been used; however, rigorous quality of life (QOL) measurements are lacking. The aim of this study was to describe unique QOL issues to formulate a specific tool for this population.

Methods:A purposive sample was identified of patients treated with intrahepatic chemotherapy. Consenting patients completed a demographic tool and the City of Hope QOL Scale/Cancer Patient survey. An in-depth interview on QOL concerns was conducted, taped, and transcribed verbatim. The data from the interviews were coded to identify recurrent themes.

Results:Sixteen patients participated. Physical well-being was maintained. Significantly lower subscale scores were noted for psychological, social, and spiritual domains compared with nonpatient norms (City of Hope volunteers; n = 169). Patients found intrahepatic chemotherapy convenient but were unable to pursue vigorous activity, and their sleep habits changed. Psychologically, patients felt reassured to receive specific therapy to their liver.

Conclusions:Pilot evaluation of QOL in this population revealed changes in physical, psychological, social, and spiritual dimensions. Both disease- and treatment-specific concerns were identified, and the results provide evidence for items to include in a QOL questionnaire specific to this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1999. CA Cancer J Clin 1999; 48: 6–29.

    Google Scholar 

  2. Kemeny N, Huang Y, Cohen A, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039–41.

    Article  CAS  PubMed  Google Scholar 

  3. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255–60.

    Article  Google Scholar 

  4. Grant M, Padilla G, Rhiner M. Assessment of quality of life with a single instrument. Semin Oncol Nurs 1990; 6: 260–70.

    Google Scholar 

  5. Padilla GV, Presant C, Grant MM, Metter G, Lipsett J, Heide F. Quality of life index for patients with cancer. Res Nurs Health 1983; 6: 117–26.

    Google Scholar 

  6. Ferrell B, Grant M, Schmidt GM, Whitehead C, Fonbuena P, Forman S. The meaning of quality of life for bone marrow transplant survivors. Cancer Nurs 1992; 15: 153–60.

    Google Scholar 

  7. Ferrell BR, Grant M, Funk R, Otis-Green S, Garcia N. Quality of life in breast cancer. Part I: physical and social well-being. Cancer Nurs 1997; 20: 398–408.

    Google Scholar 

  8. Ferrell BR, Grant M, Funk R, Otis-Green S, Garcia N. Quality of life in breast cancer. Part II: psychological and spiritual well-being. Cancer Nurs 1998; 21: 1–9.

    Google Scholar 

  9. Grant M, Ackerman D, Rivera LM. Impact of dietary counseling on quality of life in head and neck patients undergoing radiation therapy. Qual Life Res 1994; 3: 77–8.

    Google Scholar 

  10. Krouse RS, Grant M, Nelson R, Colostomies: a systematic evaluation of quality of life outcomes. J Clin Oncol (manuscript submitted for publication).

  11. Krippendorff K. Content Analysis: An Introduction to Its Methodology. Newbury Park, CA: Sze, 1980.

  12. Durand-Zaleski I, Roche B, Buyse M, et al. Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. J Natl Cancer Inst 1997; 89: 790–5.

    Google Scholar 

  13. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996; 88: 252–8.

    Google Scholar 

  14. Kemeny N, Gonen N, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001; 19: 2687–95.

    Google Scholar 

  15. Schipper H, Clinch J, Powell V, Olweny CL. Quality of life studies: definitions and conceptual issues. In: Spiker B, ed. Quality of Life Assessments in Clinical Trials. 2nd ed. New York: Lippincott, 1996: 11–23.

  16. Aaronson NK. Quality of life: what is it? How should it be measured? Oncology 1988; 2: 69–74.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah L. Blair MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blair, S.L., Grant, M., Chu, D.Z.J. et al. Quality of Life in Patients With Colorectal Metastasis and Intrahepatic Chemotherapy. Ann Surg Oncol 10, 144–149 (2003). https://doi.org/10.1245/ASO.2003.03.060

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.03.060

Key Words:

Navigation